Lanvis, Tabletten

7680378900145 CH-37890 Tabletten

Associated product:

LANVIS cpr 40 mg fl 25 pce
Lanvis, Tabletten
Lanvis, Tabletten
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
25
Selling units
25
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/04/2026
Patient information leaflet
Français
15/04/2026
Patient information leaflet
Italien
15/04/2026
Summary of Product Characteristics
Allemand
15/04/2026
Summary of Product Characteristics
Français
15/04/2026
Summary of Product Characteristics
Italien
15/04/2026

Detailed composition

Substance Quantity Type Category
tioguaninum
40.0 MG Substance Wirkstoff (Principe actif)
lactosum monohydricum
150.0 MG Substance HBESI
solani amylum
- Substance HNIDK
acaciae gummi
- Substance HNIDK
acidum stearicum
- Substance HNIDK
magnesii stearas
- Substance HNIDK

Reimbursement information

Public price
CHF 119.05
Specialties list
Yes
Generic
No
SL addition date: 15/03/1978

Authorization holder

Aspen Pharma Schweiz GmbH

6340 Baar

Authorization information

Swissmedic authorization number
37890
Drug name
Lanvis, Tabletten
Galenic form
TAB
ATC Code
L01BB03
Authorization status
Z
Dispensing category
A
First authorization
01/06/1973
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Akute Leukämie

Package details

Description (FR)
LANVIS cpr 40 mg fl 25 pce
Description (DE)
LANVIS Tabl 40 mg Fl 25 Stk
Market launch
01/06/1973
Narcotic (BTM)
No
Buy us a coffee Explore the data